In vitro effect of mitochondria-targeted triphenylphosphonium-based compounds (honokiol, lonidamine, and atovaquone) on the platelet function and cytotoxic activity

HIGHLIGHTS

• who: Mitochondria-Targeted and collaborators from the Bangladesh Agricultural University have published the paper: In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity, in the Journal: (JOURNAL) of 10/03/2022
• what: The authors evaluated the in_vitro effect of three triphenylphosphonium-based compounds, honokiol (HNK), lonidamine (LDN), and atovaquone (ATO), on the platelet function linked to the triphenylphosphonium cation by a lineal 10-carbon alkyl chain and also the decyltriphenylphosphonium salt (decylphos).
• how: The compounds were tested for the release of LDH . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.